Mecp2 regulates tnfa during zebrafish embryonic development and acute inflammation

Area of Science:

• Neuroimmunology
• Developmental Biology
• Genetics

Background:

• Mutations in the Methyl CpG binding protein 2 (MECP2) gene cause Rett syndrome, a severe neurodevelopmental disorder.
• Both MECP2 mutations and duplications are associated with significant immunological abnormalities.
• The precise role of MECP2 in regulating immune and inflammatory responses remains incompletely understood.

Purpose of the Study:

• To investigate the function of Mecp2 as an immunological regulator using a zebrafish model.
• To identify early developmental phenotypes associated with Mecp2 deficiency.
• To elucidate the role of Mecp2 in controlling inflammatory cytokine expression.

Main Methods:

• Utilized mec-p2-null zebrafish to model Mecp2 deficiency.
• Analyzed neutrophil infiltration and expression of inflammatory cytokines (Il1b, Il10, Tnfa).
• Performed RNA sequencing on mec-p2-null embryos to identify dysregulated processes.

Main Results:

• Mecp2 deficiency led to increased neutrophil infiltration and altered Il1b and Il10 expression.
• A significant downregulation of tumor necrosis factor alpha (Tnfa) was observed during development in mec-p2-null zebrafish.
• Tnfa expression was unresponsive to inflammatory stimuli and partially restored upon Mecp2 re-expression.
• RNA sequencing revealed processes predictive of Rett syndrome phenotypes.

Conclusions:

• Mecp2 is essential for regulating Tnfa expression during zebrafish development and in response to inflammation.
• Mecp2 deficiency presents the earliest described developmental phenotype in MECP2-related disorders.
• These findings highlight Mecp2's critical role in neuro-immune regulation and provide a model for studying Rett syndrome.